Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Utah Medical Products (UTMD) Shares Outstanding (Weighted Average) (2016 - 2025)

Utah Medical Products has reported Shares Outstanding (Weighted Average) over the past 16 years, most recently at $3.2 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Weighted Average) at $3.2 million for Q4 2025, down 7.51% from a year ago — trailing twelve months through Dec 2025 was $3.2 million (down 7.51% YoY), and the annual figure for FY2025 was $3.2 million, down 7.51%.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $3.2 million at Utah Medical Products, roughly flat from $3.3 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for UTMD hit a ceiling of $3.7 million in Q1 2022 and a floor of $3.2 million in Q4 2025.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $3.6 million (2023), compared with a mean of $3.5 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): grew 0.3% in 2022 and later fell 9.3% in 2025.
  • Utah Medical Products' Shares Outstanding (Weighted Average) stood at $3.6 million in 2021, then dropped by 0.27% to $3.6 million in 2022, then fell by 0.22% to $3.6 million in 2023, then fell by 3.47% to $3.5 million in 2024, then dropped by 7.51% to $3.2 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $3.2 million (Q4 2025), $3.3 million (Q3 2025), and $3.2 million (Q2 2025) per Business Quant data.